Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 26% ± 9% | |
squamous epithelial cell | 3 studies | 43% ± 21% |
Insufficient scRNA-seq data for expression of RDH13 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1636.69 | 245 / 245 | 99% | 5.75 | 499 / 502 |
esophagus | 100% | 2057.80 | 1444 / 1445 | 99% | 8.27 | 182 / 183 |
intestine | 100% | 1557.44 | 965 / 966 | 99% | 8.18 | 523 / 527 |
bladder | 100% | 1169.86 | 21 / 21 | 97% | 8.16 | 491 / 504 |
stomach | 100% | 1685.48 | 358 / 359 | 98% | 7.70 | 279 / 286 |
pancreas | 99% | 1108.47 | 326 / 328 | 97% | 8.14 | 173 / 178 |
thymus | 100% | 2254.69 | 653 / 653 | 96% | 4.03 | 583 / 605 |
uterus | 100% | 1212.58 | 170 / 170 | 96% | 8.13 | 440 / 459 |
kidney | 100% | 1606.02 | 89 / 89 | 95% | 10.76 | 858 / 901 |
breast | 98% | 1305.86 | 452 / 459 | 97% | 6.21 | 1081 / 1118 |
ovary | 99% | 878.37 | 179 / 180 | 95% | 5.88 | 408 / 430 |
lung | 99% | 1207.81 | 572 / 578 | 92% | 5.37 | 1062 / 1155 |
skin | 98% | 4312.86 | 1777 / 1809 | 90% | 4.04 | 426 / 472 |
adrenal gland | 98% | 702.12 | 252 / 258 | 82% | 3.27 | 189 / 230 |
liver | 94% | 689.12 | 213 / 226 | 64% | 2.78 | 260 / 406 |
brain | 88% | 765.66 | 2320 / 2642 | 65% | 2.15 | 459 / 705 |
spleen | 100% | 1369.52 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.47 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 5.92 | 44 / 45 |
heart | 98% | 1491.30 | 840 / 861 | 0% | 0 | 0 / 0 |
adipose | 97% | 781.31 | 1163 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 4.52 | 77 / 80 |
blood vessel | 92% | 617.35 | 1229 / 1335 | 0% | 0 | 0 / 0 |
muscle | 87% | 601.86 | 700 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 3.07 | 24 / 29 |
peripheral blood | 41% | 327.89 | 380 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042462 | Biological process | eye photoreceptor cell development |
GO_0042574 | Biological process | retinal metabolic process |
GO_0009644 | Biological process | response to high light intensity |
GO_0042572 | Biological process | retinol metabolic process |
GO_0010842 | Biological process | retina layer formation |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0052650 | Molecular function | all-trans-retinol dehydrogenase (NADP+) activity |
Gene name | RDH13 |
Protein name | Retinol dehydrogenase 13 Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3) |
Synonyms | SDR7C3 PSEC0082 UNQ736/PRO1430 |
Description | FUNCTION: Retinol dehydrogenase with a clear preference for NADP. Oxidizes all-trans-retinol, but seems to reduce all-trans-retinal with much higher efficiency . Has no activity toward steroids . . |
Accessions | ENST00000591960.1 ENST00000620423.1 [Q8NBN7-2] ENST00000592573.1 ENST00000587026.1 Q8NBN7 ENST00000415061.8 [Q8NBN7-1] ENST00000622096.4 ENST00000613935.1 [Q8NBN7-2] ENST00000622572.1 [Q8NBN7-2] ENST00000610356.4 [Q8NBN7-2] ENST00000615688.1 [Q8NBN7-2] ENST00000616337.1 G8JLA1 ENST00000587721.1 ENST00000622200.1 [Q8NBN7-2] ENST00000621614.4 [Q8NBN7-2] ENST00000396247.7 [Q8NBN7-2] ENST00000616348.1 [Q8NBN7-2] ENST00000614875.1 ENST00000621540.1 ENST00000622337.1 ENST00000621849.1 [Q8NBN7-2] ENST00000291892.10 K7EQB5 ENST00000616988.4 ENST00000615256.4 [Q8NBN7-1] ENST00000613257.1 [Q8NBN7-2] K7ERV1 K7EMY5 ENST00000586945.5 |